BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34499617)

  • 21. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
    Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
    Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis.
    Yu DP; Zhou Y
    Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
    Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
    Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
    Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
    Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma.
    Xiao W; Wang T; Ye Y; Wang X; Chen B; Xing J; Yang H; Zhang X
    Aging (Albany NY); 2021 Jan; 13(3):3536-3553. PubMed ID: 33495417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
    Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
    Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
    Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
    Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
    Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
    Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
    Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
    Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.